Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.34 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.32 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.32 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.32 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.32 |
| ▸ | DAO | P14920 | 1/20 | 0.32 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.30 |
| ▸ | ADH1B | P00325 | 1/20 | 0.30 |
| ▸ | ADH1C | P00326 | 1/20 | 0.30 |
| ▸ | ADH1A | P07327 | 1/20 | 0.30 |
| ▸ | ADH4 | P08319 | 1/20 | 0.30 |
| ▸ | ADH7 | P40394 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27475440 | 0.83 | EPHX1 (0.39) | EPHX1CHRM5CYP1A2ADRA2CCHRM2 | |
| SCHEMBL7440315 | 0.83 | EPHX1 (0.39) | EPHX1CHRM5CYP1A2ADRA2CCHRM2 | |
| SCHEMBL8976389 | 0.80 | EPHX1 (0.35) | EPHX1CHRM5CYP1A2ADRA2CCHRM2 | |
| Ammonia Solution, Strong SCHEMBL28811026 | 0.77 | EPHX1 (0.34) | EPHX1CHRM5CYP1A2ADRA2CCHRM2 | |
| SCHEMBL5215040 | 0.75 | CYP1A2 (0.39) | CHRM5CYP1A2ADRA2CCHRM2CHRM4 | |
| SCHEMBL9802627 | 0.74 | EPHX1 (0.38) | EPHX1CHRM5CYP1A2ADRA2CCHRM2 | |
| SCHEMBL20867079 | 0.74 | CYP1A2 (0.42) | EPHX1CHRM5CYP1A2ADRA2CCHRM2 | |
| SCHEMBL12960855 | 0.74 | CYP1A2 (0.42) | EPHX1CHRM5CYP1A2ADRA2CCHRM2 | |
| SCHEMBL27985770 | 0.74 | EPHX1 (0.31) | EPHX1ADH1BADH1CADH1AADH4 | |
| SCHEMBL10311789 | 0.73 | ALOX5 (0.43) | EPHX1CHRM5CHRM2CHRM4CHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1982978-B1 | PYRIDONE DERIVATIVE AND HERBICIDE | KUMIAI CHEMICAL INDUSTRY CO (JP) | 2014-08-27 | — | — | EP | disclosed |
| US-8076487-B2 | Pyridone derivative and herbicide | KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) | 2011-12-13 | — | — | US | disclosed |
| US-20100222592-A1 | Pyridone Derivative and Herbicide | KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) | 2010-09-02 | — | — | US | disclosed |
| EP-1982978-A1 | PYRIDONE DERIVATIVE AND HERBICIDE | KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) | 2008-10-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100222592-A1 | Pyridone Derivative and Herbicide | PDXK, PNPO, CBR3 | EPHX1 1271/4885CHRM5 416/4885CYP1A2 47/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.